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IN VITRO STUDIES ON THE FUNGISTATIC EFFECT OF
ANTIHISTAMINIC DRUGS*
WILLSON J. FAHLBERG, Pu.D.
The antihistaminic drugs have been shown to be of some value in the therapy
of cutaneous diseases. In 1950, Carson and Campbell (1) at the Army Medical
School, reported that several cases of tinea pedis (athlete's foot) responded well
to the local application of a cream containing two percent Pyribenzamine. On
the basis of this observation, the authors undertook a study to determine whether
the effect noted was solely against the allergic manifestations incited by the fungi
causing the disease or against the fungi themselves. Their results suggested that
di-phenyl-pyraline and Pyribenzamine possessed fungistatic activity. Landis
and Krop (2) studied the influence of histamine upon the fungistatic action of
various antihistamines. They were able to show that the, fungistatic action was
prevented by suitable amounts of histamine, and the authors established the
minimum fungistatic levels for a number of the antihistaminic drugs. Other in-
vestigators (3, 4, 5) have reported both in vitro and in vivo studies on certain of
the antihistamines.
These reports suggested the investigation of the relative fungistatic action in
vitro of a group of the principal antihistaminic agents.
MATERIALS AND METHODS
Antihistamines
The eight antihistaminic compounds studied were as follows: (1) Benadryl,
(diphenhydramine hydrochloride) Parke-Davis; (2) Thenylene, (methapyrilene
hydrochloride) and (3) Di-Paralene, (chlorocyclizine hydrochloride) Abbott; (4)
Neo-Antergan, (pyriamine maleate) Merck; (5) IDiatrine, (methaphenilene hy-
drochloride) Wm. R. Warner; (6) Thephorin, (phenindamine tartarate) Hoffman-
La Roche; (7) Pyribenzamine, (tripelennamine hydrochloride) Ciba; (8) Theo-
phylline Ethylenediamine, (aminophylline) Lederle. I
Fungows cultures
The fungi employed were transplants of pure cultures all isolated from clinical
cases of superficial or systemic mycoses in man. They had been maintained in
the laboratory on Sabouraud's maltose agar. The species of dermatophytes in-
cluded Trichophyton Schoenleini, Trichophyton tonsurans, Trichophyton violaceum,
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Trichophyton mentagrophytes, Trichophyton concentricum, Trichophyton rubrum,
Epidermophyton floccosurn, Ilormodendrum corn pactum, Hormodendrum Pedrosoi,
Monosporiurn apiospermurn, Phialophora verrucosa, Micros porum canis, Micro-
sporurn Audouini, and Microsporum gypseurn. The fungi causing systemic infec-
tions employed were Histo plasma capsulaturn, Blastornyces dermatitidis, Candida
albicans, Cry ptococcus neoformans and Sporotrichum &henckii.
Procedure
Tubes of Sabouraud's maltose broth were made up in 2.0 ml amounts, each
containing 0.1 mg, 0.25 mg, 0.5 mg, 0.75 mg, 1.0 mg, 2.0 mg, 3.0 mg, and 5.0 mg
per milliliter, respectively, of the various antihistamines. The pH values of the
various solutions were measured after autoclaving.
All of the test organisms were grown on Sabouraud's maltose agar slants, incubated for
four weeks at room temperature. The growth was removed aseptically, taking as little of
the agar as possible, and placed in a sterile tube containing glass beads and sterile saline.
The tubes were then mechanically shaken for 30 minutes, and 0.05 ml of this suspension
was inoculated into the series of broth tubes containing increasing concentrations of the
antihistarninic drugs, as described above. The tubes were kept at room temperature (ap-
proximately 28°C) for 30 days and readings were made at four day intervals. The growth
in the test cultures was recorded as one to four plus on the basis of comparison with that
in the control broth tubes. All experiments were performed in triplicate.
Of the Sabouraud's maltose broth used for the controls, one portion was ad-
justed to a pH of 5.8 and the other to a pH of 4.8. These p11 values represented
the extreme ranges of pH variation observed in the broth containing the antihis-
tamine compounds. Controls were all run in triplicate.
A disc technic similar to that outlined by Carson and Campbell (1) was em-
ployed to test the effectiveness of the antihistamine in the presence of serum; the
only modification being the use of sterile one-half inch antibiotic discs for the
antihistamines in lieu of the penicylinders.
To determine whether the activity of the antihistamines was fungicidal or
fungistatic in nature, the Golden and Oster (6) technic as modified by Walker,
et al. (4) was followed.
RESULTS
In recording the results of the antihistamine-broth cultures, restriction was
considered to have taken place if a comparison with the control tubes indicated
substantially less growth in thirty days. Inhibition was recorded if there was no
evidence of growth at the end of thirty days.
As shown in Table I, Neo-Antergan, Theophylline, Thenylene, and Pyribenza-
mine generally exhibited no inhibitory action at concentrations up to 1.0 mg/mI.
However, both restriction and inhibition of growth were evident at levels of 2.0
and 5.0 mg/ml with Pyribenzamine and Thenylene. Neo-Antergan and Theo-
phylline, with rare exceptions, were unable to inhibit the growth of most of the
fungi tested, even at levels of 5.0 mg/ml, although restriction did take place.
Table II indicates that Benadryl restriectd the growth of most of the fungi
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tested at levels of 1.0 mg/mi and Thephorin restricted the growth of all of the
fungi tested at levels of 0.25 to 5.0 mg/mi. Both antihistamines were able to
inhibit the majority of the fungi tested at the 2.0 and 5.0 mg/mi level. The one
notable exception was C. albicans, which was not inhibited by either drug at the
5.0 mg/mi level. Diatrine at fairly low levels displayed an ability to restrict all
of the fungi tested. The restriction was most marked the first eight days of cul-
tivation and became progressively less. The inhibitory ability of the drug closely
paralleled that of Thephorin with the two yeast cultures (C. neoformans and C.
albicans) tolerating a high level of drug. The most effective antihistamine drug
of the eight tested proved to be Di-Paralene. Drug levels as low as 0.25 mg/mi
TABLE I
The in vitrofungitatic activity of pyribenzamine, thenylene, n.eo-antergan, and theophytline
PTJNGI
PYRIBEN
R
ZAMiNE
I
THENY
R
LENE
1
NZO-A
R'
NTERGAN
1
TBEOP
R
HYLLINE
J
T.Schoenleini >1.0 >0.1 >1.0 >1.0 >1.0 >1.0 >1.0 >1.0
T. tonsurans >1.0 >1.0 >1.0 >1.0 1.0 >1.0 >1.0 >1.0
T. violaceum >1.0 >1.0 >1.0 >1.0 >1.0 >1.0 >1.0 >1.0
T. mentagrophytes >1.0 2.0 2.0 5.0 2.0 >5.0 >5.0 >5.0
M. canis >1.0 >1.0 >1.0 >1.0 >1.0 >1.0 >1.0 >1.0
M. Audouini >1.0 2.0 2.0 5.0 1.0 5.0 2.0 5.0
M. apiospermum 2.0 5.0 2.0 5.0 5.0 >5.0 >5.0 >5.0
M. gypseum 2.0 5.0 2.0 5.0 5.0 >5.0 5.0 >5.0
T. concentridum >1.0 >1.0 >1.0 >1.0 >1.0 >1.0 >1.0 >1.0
T. rubrum >1.0 >1.0 >1.0 >1.0 >1.0 >1.0 >1.0 >1.0
P. verrucosa 2.0 5.0 1.0 5.0 5.0 >5.0 >5.0 >5.0
H. compactum >1.0 2.0 1.0 2.0 2.0 5.0 1.0 2.0
H. Pedrosoi >1.0 >1.0 >1.0 >1.0 >1.0 >1.0 >1.0 >1.0
E. floccosum >1.0 >1.0 >1.0 >1.0 >1.0 >1.0 >1.0 >1.0
S. Schenkii 2.0 5.0 2.0 5.0 5.0 >5.0 5.0 >5.0
H. capsulatum >1.0 2.0 2.0 5.0 2.0 5.0 5.0 >5.0
B. dermatitidis >1.0 >1.0 >1.0 >1.0 1.0 >1.0 1.0 >1.0
C. albicans >5.0 >5.0 >5.0 >5.0 >5.0 >5.0 >5.0 >5.0
C. neoformans 2.0 5.0 2.0 5.0 2.0 >5.0 5.0 >5.0
* R = mg of drug per milliliter required for restriction of growth.I = mg of drug per milliliter required for complete inhibition of growth.
were restrictive for the majority of the fungi. Complete inhibitior was evidenced
at levels of 0.5 to 0.75 mg/mi. The one exception was C. neoformans, which re-
quired 2.0 mg/mi for complete inhibition.
To test the effect of the presence of serum in Sabouraud's medium the proce-
dure outlined by Carson and Campbell (1) was followed. The organism first em-
ployed was C. albicans. Following a heavy inoculation of the plate with the test
organism, sterile one half inch antibiotic discs containing known amounts of the
various antihistamines were placed on the surface. Diameters of the zones of
inhibition were measured at 72 hours. No significant differences were found
between duplicate plates.
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Table III indicates that Thenylene, Pyribenzamine, Neo-Antergan, and Theo-
phyffine required levels of 10 mg/disc to produce an inhibitory zone of apprecia-
ble size. The presence of 10 per cent horse serumslightly enhanced the activity
of Thenylene, Pyribenzamine, and Theophylline. On the other hand, the activity
of Neo-Antergan was almost completely negated by horse serum. Thephorin,
Benadryl, and Diatrine showed at the most slight activity in the absence of horse
serum at the 2.5 mg/mi level, but in its presence a definite enhancement of activ-
ity was observed. The degree of enhancement was fairly constant regardless of
TABLE II
The in vitro fun qi8tatic activity of diatrine, di-paralene, benadryl, and thephorin
DIATRINE MG/ML DIPARALENE BENADRYL THEPHORIN
FUNGI
P R PR* 1 R R P
T.Schoenleini 0.75 >1.0 0.25 0.50 0.75 >1.0 1.0 >1.0
T.tonsurans 0.25 >1.0 0.25 0.75 1.0 >1.0 1.0 >1.0
T.violaceum 1.0 >1.0 0.25 0.50 >1.0 >1.0 0.75 >1.0
T.mentagrophytes 0.25 2.0 0.10 0.25 1.0 2.0 1.0 2.0
M. canis 0.50 >1.0 0.50 0.75 >1.0 >1.0 1.0 >1.0
M. Audouini 0.50 2.0 0.25 0.50 1.0 2.0 1.0 2.0
M.Apiospermum 0.75 2.0 0.25 0.75 1.0 >5.0 1.0 2.0
M. gypseum 0.75 2.0 0.25 0.75 <2.0 2.0 1.0 2.0
T.concentricum 1.0 >1.0 0.25 0.50 1.0 >1.0 1.0 >1.0
T.rubrum 0.50 >1.0 0.10 0.50 1.0 >1.0 0.75 >1.0
P. verrucosa 0.10 0.75 0.25 0.75 0.50 2.0 0.25 0.75
H. compactum 0.25 2.0 0.25 0.50 0.5 2.0 0.75 2.0
H. Pedrosi 0.25 >1.0 0.25 0.50 >1.0 >0.0 1.0 >1.0
E.fioccosum 0.75 >1.0 0.10 0.75 >1.0 >1.0 1.0 >1.0
S. Schenkii 1.0 3.0 0.25 0.75 2.0 5.0 0.75 2.0
H. capsulatum 0.50 2.0 0.25 0.50 1.0 5.0 0.75 2.0
B. dermatitidis
C. albicans+
C. neoformans+
0.50 >1.0 0.25
0.25
0.75
0.50
0.75
2.0
1.0 >1.0
>5.0 >5.0
2.0
0.75
5.0
1.0
>1.0
>5.0
2.0
Not restricted at
3 mg/mi ievei
2mg/mi 3 mg/mi
= mg of drug per milliliter required for restriction of growth.
I = mg of drug per milliliter required for complete inhibition of growth.
+ Two different strains of these fungi were tested with comparable results.
the amount of the drug placed on the disc in the case of Bendryl and Thephorin.
With Diatrine at the level of 10 mg/disc, no difference between zone sizes in the
presence or absence of horse serum was observed. Di-Paralene activity showed
no change in the presence of horse serum when compared with its controls at
levels from 1.0 mg/mi to 10 mg/mi.
Comparable results on the effect of serum were obtained in another series of
tests employing C. neoformans as the test organism, with the exception that in
general considerably higher levels of the antihistamines were required to produce
inhibitory zones.
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The Walker, et al. (4) modification of the Golden and Oster (6) technic for
testing for fungicidal activity was employed to analyze the action of Benadryl,
Diatrine, Thephorin, and Di-Paralene. Fifteen-day-old cultures of A. fumigatus,
C. albicans, M. apiospermum, M. Audouini, M. gypseum, S. Schenkii, and T.
mentagrophytes grown on ten per cent horse serum Sabouraud's maltose agar,
were used as the test organisms. Two immersion times in the test solution were
employed. The first time was a one-minute contact as suggested by Golden and
Oster. The results indicated that only T. mentagrophytes was killed by Diatrine
at the 3 mg/mi level, Thephorin at the 3 mg/ml level and Di-Paralene at the 1
mg/mi level. Bendryl had no effect at the 5 mg/mi level, and the growth of none
TABLE III
ANTIHISTAmNE DRUG LEVEL ZONE DIA&ETZR
mg. 6tH.
Thenylene 10 2.0
Thenylene & Horse Serum 10 2.5
Pyribenzamine 10 2.0
Pyribenzamine & Horse Serum 10 2.6
Neo-Antergan 10 2.7
Neo-Antergan & Horse Serum 10 0.2
Theophylline 10 2.3
Theophylline & Horse Serum 10 3.0
Thephorin 2.5 0.2
Thephorin & Horse Serum 2.5 1.2
Benadryl 2.5 0.0
Benadryl & Horse Serum 2.5 2.0
Diatrine 2.5 slight
Diatrine & Horse Serum 2.5 2.0
Di-Paralene 1.0 2.7
Di-Paralene & Horse Serum 1.0 2.8
of the other fungi tested were altered by any of the antihistamines at levels up
to 5 mg/mi. A second contact time of five minutes was tried, but in the majority
of cases the controls with the 95 per cent ethyl alcohol were inhibited, thus invali-
dating the experiment. In no instance did the 30 per cent acetone controls inhibit
the growth of the fungi.
COMMENT
While some of our results on the fungistatic levels of the various antihista-
mines are not directly comparable with those obtained by Carson and Campbell
or Landis and Krop, it is felt that the differences can be rationalized on the
basis of strain variation within the species.
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SUMMARY
1. The descending order of effectiveness of the antihistamine as fungistatic
agents was as follows: Di-Paralene, Diatrine, Thephorin, Benadryl, Pyribenza-
mine, Thenylene, Theophylline, and Neo-Antergan.
2. Di-Paralene was the most effective drug tested, having a fungistatic activ-
ity in amounts of 0.5 to 0.75 mg/mi for all the fungi tested, except C.neoformans,
which required 2.0 mg/mi for complete inhibition.
3. The presence of 10 per cent serum in most cases enhanced the fungistatic
activity of the drugs. Two exceptions, Neo-Antergan in which the activity was
negated and Di-Paralene in which there was no effect, were observed.
4. No clear evidence of fungicidal activity could be shown for even the most
active fungistatic antihistamines, i.e., Thephorin, Diatrine, or Di-Paralene.
At the present time, studies on the clinical application of Di-Paralene are being
pursued, as well as tests for its effect upon experimental systemic mycoses in
laboratory animals.
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